How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies

by Pusceddu, Sara, De Braud, Filippo, Russo, Giuseppe Lo, Concas, Laura, Femia, Daniela, Vernieri, Claudio, Indini, Alice, Formisano, Barbara, Buzzoni, Roberto
Published in Oncotarget (2016)

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

by Pusceddu, Sara, Verzoni, Elena, Prinzi, Natialie, Mennitto, Alessia, Femia, Daniela, Grassi, Paolo, Concas, Laura, Vernieri, Claudio, Lo Russo, Giuseppe, Procopio, Giuseppe
Published in Ther Adv Med Oncol (2017)

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up

by Vernieri, Claudio, Femia, Daniela, Pusceddu, Sara, Capella, Carlo, Rosai, Juan, Calareso, Giuseppina, Concas, Laura, Prinzi, Natalie, Russo, Giuseppe Lo, de Braud, Filippo, Buzzoni, Roberto
Published in Case Rep Oncol (2016)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors

by Berardi, Rossana, Torniai, Mariangela, Pusceddu, Sara, Spada, Francesca, Ibrahim, Toni, Brizzi, Maria Pia, Antonuzzo, Lorenzo, Ferolla, Piero, Panzuto, Francesco, Silvestris, Nicola, Partelli, Stefano, Ferretti, Benedetta, Freddari, Federica, Gucciardino, Calogero, Testa, Enrica, Concas, Laura, Murgioni, Sabina, Bongiovanni, Alberto, Zichi, Clizia, Riva, Nada, Rinzivillo, Maria, Brunetti, Oronzo, Giustini, Lucio, Di Costanzo, Francesco, Delle Fave, Gianfranco, Fazio, Nicola, De Braud, Filippo, Falconi, Massimo, Cascinu, Stefano
Published in Cancer Med (2017)